
A biomedical collaboration story about a university gaining access to a transgenic mouse platform for generating fully human antibodies, useful for researchers interested in infectious disease discovery and translational antibody tools.
Key Takeaways
- Collaboration enables the inter-university Ignaz Semmelweis Institute – directed by Prof
- H2L2 Harbour Mice ® platform and all associated intellectual property rights remain vested in Nona Biosciences
- "We are delighted to partner with the Medical University of Vienna
